12-Week Treatment with LY2409021 Significantly Lowers HbA1C and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus

Article Figures & Data

Figures

  • Figure 1.

    miTT Population: Mean Change from Baseline in HbA1C at Week 12.

    LS=least squares; miTT=modified intention-to-treat; MMRM=Mixed Model Repeated Measures.Reproduced with permission from CM Kazda, MD.
  • The editors would like to thank the many members of the EASD Congress 2012 presenting faculty who generously gave their time to ensure the accuracy and quality of the articles in this publication.